Repare Therapeutics
Stock Forecast, Prediction & Price Target
Repare Therapeutics Financial Estimates
Repare Therapeutics Revenue Estimates
Repare Therapeutics EBITDA Estimates
Repare Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $7.6M N/A | $131.83M 1634.60% | $51.13M -61.21% | Avg: $11.16M Low: $4.00M High: $20.04M avg. -78.17% | Avg: $44.18M Low: $31.49M High: $62.55M avg. 295.92% | Avg: $77.49M Low: $55.23M High: $109.70M avg. 75.39% | Avg: $156.10M Low: $111.26M High: $220.97M avg. 101.42% |
Net Income
% change YoY
| $-106.90M N/A | $-29.04M 72.82% | $-93.79M -222.91% | Avg: $-168.11M Low: $-172.16M High: $-102.70M avg. -79.23% | Avg: $-154.45M Low: $-158.27M High: $-78.29M avg. 8.12% | Avg: $-99.55M Low: $-153.33M High: $-62.37M avg. 35.54% | Avg: $-68.89M Low: $-106.11M High: $-43.16M avg. 30.79% |
EBITDA
% change YoY
| $-108.51M N/A | $-20.10M 81.47% | $-114.27M -468.40% | Avg: $-4.80M Low: $-8.62M High: $-1.72M avg. 95.79% | Avg: $-19.02M Low: $-26.92M High: $-13.55M avg. -295.92% | Avg: $-33.36M Low: $-47.22M High: $-23.78M avg. -75.39% | Avg: $-67.20M Low: $-95.12M High: $-47.89M avg. -101.42% |
EPS
% change YoY
| -$2.83 N/A | -$0.69 75.61% | -$2.23 -223.18% | Avg: -$3.21 Low: -$4.09 High: -$2.44 avg. -43.94% | Avg: -$3.09 Low: -$3.76 High: -$1.86 avg. 3.73% | Avg: -$2.37 Low: -$3.64 High: -$1.48 avg. 23.46% | Avg: -$1.64 Low: -$2.52 High: -$1.03 avg. 30.79% |
Operating Expenses
% change YoY
| $116.26M N/A | $151.62M 30.41% | $167.35M 10.37% | Avg: $249.14M Low: $89.50M High: $447.50M avg. 48.87% | Avg: $986.43M Low: $703.09M High: $1.39B avg. 295.92% | Avg: $1.73B Low: $1.23B High: $2.44B avg. 75.39% | Avg: $3.48B Low: $2.48B High: $4.93B avg. 101.42% |
FAQ
What is Repare Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -1.19% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -172.16M, average is -168.11M and high is -102.70M.
What is Repare Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 98.64% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $4.00M, average is $11.16M and high is $20.04M.
What is Repare Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 3.51% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$4.09, average is -$3.21 and high is $-2.44.
What is the best performing analyst?
In the last twelve months analysts have been covering Repare Therapeutics stock. The most successful analyst is Joseph Catanzaro.